SLC26A5 and hearing loss disorder: In vitro, methyl-β-cyclodextrin shifts the voltage range of prestin-associated motility [7], raising the possibility that HPβCD-related hearing loss at low frequencies could be related to prestin dysfunction in surviving OHCs.